Skip to content
Search

Latest Stories

Fire at India's Serum Institute; coronavirus drug production 'not affected'

Fire at India's Serum Institute; coronavirus drug production 'not affected'

A fire broke out Thursday(21) at India's Serum Institute, the world's largest maker of vaccines, but a company source said production of drugs to prevent coronavirus was not affected.

The Serum Institute is producing millions of doses of the Covishield coronavirus vaccine, developed by AstraZeneca and Oxford University, for India and many other countries.


Local TV channels showed thick clouds of grey smoke billowing from the sprawling site in Pune, in western India.

"It is not going to affect production of the Covid-19 vaccine," a source at the Serum Institute told AFP, adding that the blaze was at a new plant under construction.

An official at the local fire station said that six or seven firetrucks had reached the site, spread over 100 acres (40 hectares).

Three people were reported to have been rescued from the blaze, with another unaccounted for.

"Thick smoke is hampering the work of bringing the fire under control," the fire brigade told NDTV.

The complex where the fire broke out is a few minutes drive from the facility where the coronavirus vaccines are produced, reports said.

Eight or nine buildings are under construction at the complex to enhance its manufacturing capability, NDTV reported.

Huge vaccine rollout

Serum Institute -- founded in 1966 by Cyrus Poonawalla -- is the world's largest vaccine manufacturer by volume, producing 1.5 billion doses a year even before the coronavirus pandemic.

It makes vaccines against polio, diphtheria, tetanus, hepatitis B, measles, mumps and rubella, which are exported to more than 170 countries.

The company has spent nearly a billion dollars in recent years enlarging and improving the giant Pune campus.

In January, Indian regulators approved two vaccines -- Covishield, produced by the Serum Institute, and Covaxin, made by local firm Bharat Biotech.

India began one of the world's biggest vaccine rollouts on Saturday, aiming to vaccinate 300 million people by July with both Covishield and Covaxin.

Many other countries are relying on the Serum Institute to supply them with the vaccine.

India exported its first batch on Wednesday(20) -- to Bhutan and the Maldives -- followed by two million doses to Bangladesh and a million to Nepal.

The country plans to offer 20 million doses to its South Asian neighbours, with Latin America, Africa and Central Asia next in line.

Serum Institute also plans to supply 200 million doses to Covax, a World Health Organization-backed effort to procure and distribute inoculations to poor countries.

Brazil last weekend was set to send a plane to collect two million doses from Serum but President Jair Bolsonaro said that "political pressure" in India had postponed the flight.

Serum chief Adar Poonawalla told the Times of India it would supply Brazil in two weeks.

More For You

What Makes the 'Nimbus' Covid Variant Symptoms Different?

Experts warn that nimbus may be more efficient at infecting human cells than earlier variants

iStock

Doctors warn of new covid symptom as nimbus variant spreads across the UK

A new covid variant, known as nimbus (scientifically NB.1.8.1), is causing concern among health experts as cases rise globally. The variant, a descendant of omicron, has been detected in several countries, including China, Singapore, Hong Kong, and the UK. While its symptoms are largely similar to previous covid strains, doctors have identified a distinctive new symptom: a razor blade sore throat, characterised by an intense stabbing pain when swallowing.

Experts warn that nimbus may be more efficient at infecting human cells than earlier variants, which could lead to increased transmission rates. Although there is no current evidence to suggest that it causes more severe illness than its predecessors, the rapid spread has raised concerns, particularly among vulnerable groups.

Keep ReadingShow less
Sands Extends Special Father’s Day Support to Bereaved Fathers

The charity is encouraging individuals to honour a bereaved father with a special online dedication

iStock

This Father’s Day, Sands charity offers vital support to bereaved fathers

As Father’s Day approaches, the UK’s leading pregnancy and baby loss charity, Sands, is extending vital support to grieving fathers and their families. With Sunday, 15 June, likely to be a challenging day for many, the charity is making special efforts to ensure bereaved dads do not feel alone.

Sands has announced extended hours for its confidential Freephone Helpline (0808 164 3332), which will be open from 10 am to 12 pm on Father’s Day. This service offers a safe, non-judgmental space for those affected by pregnancy or baby loss to talk and seek support. Support is also available via email (helpline@sands.org.uk) and through the charity’s online community atwww.sands.community.

Keep ReadingShow less
Sadhvi Bhagawati Saraswati to Celebrate 25 Years of Monastic Life on June 11

Sadhviji, a renowned spiritual teacher and author

Parmarth Niketan

Sadhvi Bhagawati Saraswati to celebrate 25 years of monastic life on June 11

Parmarth Niketan will mark the 25th sanyas anniversary of Pujya Sadhvi Bhagawati Saraswatiji on 11 June, honouring her quarter-century of spiritual service and dedication since she took monastic vows in 2000.

The ceremony will be held on the sacred Shri Rama Katha stage at Parmarth Niketan in Rishikesh and will feature blessings from several prominent spiritual leaders. Among those attending are Pujya Swami Chidanand Saraswatiji, Pujya Swami Ramdevji, mahamandaleshwars Rajendra Dasji, Ravindra Puriji and Harichetnanandji, as well as Pujya Sadhvi Ritambharaji, Pujya Acharya Balkrishanji, Dr Chinmaya Pandyaji and others.

Keep ReadingShow less
NHS Issues Emergency Appeal for 200,000 Blood Donors as Supplies Dwindle

NHS Blood and Transplant (NHSBT) is aiming to boost the number of active donors to one million to meet growing demand

iStock

NHS appeals for 200,000 more donors as blood stocks fall dangerously low

The NHS has launched an urgent appeal for more people to come forward for blood donation, warning that a shortage of over 200,000 donors in England could pose a risk to public safety. NHS Blood and Transplant (NHSBT) is aiming to boost the number of active donors to one million to meet growing demand.

Blood supplies under pressure

Currently, fewer than 800,000 people – just 2% of England’s population – give blood regularly. This small group kept the NHS running last year, but officials say more support is needed. A severe drop in supply last year led to an amber alert, and NHSBT warns that without more blood donations, the situation could escalate to a red alert, meaning hospitals may not have enough blood for patients in critical need.

Keep ReadingShow less